In this webinar, experts present an overview of systematic literature reviews, detailing their purpose, execution, decision-making criteria, and suitability for addressing key questions in the pharmaceutical industry.
Evidence acquisition and analysis remain important responsibilities for many teams in the pharmaceutical industry, providing key drivers for insights and strategic decisions. However, with limited time and funds, not all questions can or should be addressed with new evidence generation. Systematic literature reviews (SLRs) are protocol-driven, comprehensive evaluations of published or otherwise accessible information that are designed to answer specific questions. They have the potential to provide more complete answers with less bias than less stringent literature analyses by requiring detailed protocol development before the search, and careful review and data analysis steps with multiple analysts.
These reviews play an important role as gap analyses to determine where new evidence generation is necessary and identify and summarize existing information to support internal education and external communication objectives. However, the inner workings of the systematic literature review process are not always clear, and their systematic nature creates a unique set of challenges, such as bookkeeping, addressing a paucity of data, rapidly evolving literature, and potential for expanded scopes of work.
This webinar aims to provide an overview of systematic literature reviews as a tool, including what they are, how they are conducted, when to perform a systematic literature review versus less stringent literature analysis approaches, and who should consider systematic literature reviews as a tool to address important questions.
Key Topics Include:
- Describe what an SLR is and how its methodology makes this approach uniquely comprehensive compared with other literature analyses
- Design systematic literature reviews and interpret findings to answer specific questions required to achieve team objectives
Presenters
Cory Pfeiffenberger
Cory is a senior scientific manager at ICON plc and brings more than 10 years agency and consulting experience in medical communications and medical affairs. He is an experienced professional in developing and executing systematic literature reviews supporting diverse needs including epidemiology education and regulatory submission. Cory is a Certified Medical Publication Professional (CMPP) and an active member of the International Society for Medical Publication Professionals (ISMPP).
Rebecca Rozich
Rebecca is a senior-level communications professional with a demonstrated record of success in medical communications, medical strategy, and publication planning. She has extensive experience in the development of medical communication and publication strategy and tactics across many therapeutic areas. Rebecca oversees a team responsible for the strategic development and tactical management of scientific and medical communication plans for pre- and postlaunch products for major pharmaceutical and biotech companies.
Moira Hudson
Moira is a scientific lead at ICON plc and brings more than 25 years’ experience in medical communications gained in both academic and agency settings. She is experienced in carrying out systematic literature reviews to support varied client needs. Moira is a Certified Medical Publication Professional (CMPP) and an active member of the International Society for Medical Publication Professionals (ISMPP).
Sponsor
